Connect with us

Asia

Hong Kong suspends its order of AstraZeneca jabs

Published

on

Hong Kong on Friday confirmed it has requested AstraZeneca suspend delivery of its Covid-19 vaccine amid fears of severe side effects and concerns over its efficacy against new variants of the coronavirus.

Europe’s medicines regulator said this week the AstraZeneca vaccine could cause very rare blood clots in some recipients, prompting a cascade of countries to pull the plug on giving it to people under a certain age.

Britain sought Thursday to quell fears over the jab, saying the potential side effects were extremely rare — and the risk of falling seriously sick from Covid-19 was far greater.

On Friday Hong Kong’s health chief Sophia Chan said the city has asked AstraZeneca not to deliver as planned later this year.

“We think it is not necessary for AstraZeneca to deliver the vaccines to the city within this year,” she said, adding Hong Kong wanted “to avoid any waste as vaccines are in short supply globally”.

Wealthy Hong Kong has already secured a good supply of vaccines for its 7.5 million residents.

It has signed deals for 7.5 million shots each with BioNTech/Pfizer and China’s Sinovac, both of which have begun deliveries.

Chan said Hong Kong was also keen to look at other vaccines that may have stronger results against newer strains of the coronavirus.

Earlier this week David Hui, a leading public health expert and government adviser, called for Hong Kong to replace AstraZeneca with a new single dose vaccine made by Johnson and Johnson.

Densely populated Hong Kong was one of the first places to be hit by the coronavirus, but strict social distancing and universal mask wearing have helped keep infections to just over 11,000 with 205 deaths.

While it has a steady supply of vaccines, take up has been slow amid swirling distrust of the government as Beijing cracks down on democracy supporters.

So far just 529,000 people have had their first dose.

Public confidence has also been hampered by government messaging.

China’s Sinovac received fast-track approval despite not publishing its clinical trial data in a peer reviewed journal.

Administration of BioNTech’s vaccine was also briefly suspended after some vials were found to be defective even though authorities said any damaged bottles were discarded before being used in vaccinations.

– AFP

Continue Reading
Click to comment
Subscribe
Notify of
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Asia

Up to 200 athletes tested for doping so far at Asian Games

Between 150 and 200 Asian Games athletes tested for doping, yielding no positive results. Anti-doping efforts emphasized for a clean event, focusing on record-breakers.

Published

on

HANGZHOU, CHINA — Between 150 and 200 Asian Games athletes have already been tested for doping, the Olympic Council of Asia said on Monday, with no positive results so far.

Speaking at an anti-doping press conference on the second full day of the Games in the Chinese city of Hangzhou, the OCA said dope-testing was “gaining momentum” at the event.

Mani Jegathesan, an adviser to the OCA anti-doping committee, warned that drug cheats would be rooted out.

Up to 200 athletes have been tested so far, he said, but any positive results will take several days to come through.

“Every athlete participating in these Games must understand that they could be picked at any time,” Jegathesan warned.

“That is the best step to ensuring we have a clean event.”

There are about 12,000 athletes at the 19th Asian Games, more competitors than the Olympics, and Jegathesan admitted it would be impossible to test them all.

Instead, they will prioritise, including picking out those who break world or Asian records.

— AFP

Continue Reading

Asia

Foodpanda’s restructuring amid sale speculations

Food delivery giant Foodpanda, a subsidiary of Delivery Hero, announces staff layoffs in the Asia-Pacific region, aiming for increased efficiency. This move coincides with ongoing talks about potentially selling parts of its 11-year-old business.

Published

on

Foodpanda, a subsidiary of Delivery Hero, is initiating undisclosed staff reductions in the Asia-Pacific region, as discussions continue regarding the potential sale of a portion of its 11-year-old food delivery business.

In a memorandum circulated to employees on 21 September, Foodpanda CEO Jakob Angele conveyed the company’s intent to become more streamlined, efficient, and agile.

Although the exact number of affected employees was not disclosed, the emphasis was on enhancing operational efficiency for the future.

No mention was made in the memo regarding the reports of Foodpanda’s potential sale in Singapore and six other Southeast Asian markets, possibly to Grab or other interested buyers.

Foodpanda had previously conducted staff layoffs in February and September 2022. These actions come as the company faces mounting pressure to achieve profitability, particularly in challenging economic conditions.

The regulatory filings of Foodpanda’s Singapore entity for the fiscal year 2022, ending on 31 Dec, indicated a loss of S$42.7 million despite generating revenue of S$256.7 million.

Angele further explained that Foodpanda intends to review its organizational structure, including both regional and country teams, with some reporting lines being reassigned to different leaders. Additionally, certain functions will be consolidated into regional teams.

Expressing regret over the challenging decisions, Angele assured affected employees of a severance package, paid gardening leave, and extended medical insurance coverage where feasible.

Foodpanda will also forego the usual waiting period for long-term incentive plan grants, and vesting will continue until the last employment date. Employees will retain all vested shares as of their last day of employment.

Foodpanda, established in 2012 and headquartered in Singapore, became a part of Delivery Hero in 2016. The company operates in 11 markets across the Asia-Pacific region, excluding its exit from the Japanese market last year.

Continue Reading

Trending